CTIS.eu › Cities › Greece › Heraklion
Heraklion
Greece
231 total trials
100 recruiting
2025-522598-12-00
10
2025-12-17
Untreated Metastatic Pancreatic Ductal Adenocarcinoma
2025-521096-31-00
5
2025-10-02
Chronic Hepatitis C Virus (HCV) Infection
2024-516745-39-00
4
2025-07-11
Cutaneous lupus erythematosus
2024-516051-40-00
4
2025-06-10
Small Cell Lung Cancer (SCLC)
2024-513282-39-00
5
2025-05-28
Hidradenitis Suppurativa (HS)
2024-512925-95-00
5
2025-05-16
Advanced/Metastatic Breast Cancer
2024-513968-25-00
5
2025-04-28
Metastatic castration-resistant prostate cancer (mCRPC)
2022-501483-18-00
10
2025-03-28
Advanced Non-Small Cell Lung Cancer
2024-516213-20-00
5
2025-03-25
Psoriatic arthritis
2024-515255-38-00
4
2025-03-12
SEPSIS
2024-512998-27-00
5
2025-02-21
Non-Small Cell Lung Cancer
2023-509069-19-00
4
2024-12-12
idiopathic pulmonary fibrosis
2023-508636-61-00
5
2024-10-24
Crohn’s Disease
2024-510584-37-00
4
2024-10-22
Systemic Lupus Erythematosus
2023-509600-15-00
5
2024-10-18
Type 2 Diabetes
2024-512676-36-00
10
2024-10-09
Langerhans Cell Histiocytosis
2023-503714-77-00
4
2024-10-01
Advanced Non-Small Cell Lung Cancer
2024-511705-31-00
5
2024-09-26
Arterial Hypertension
2023-507851-31-00
5
2024-09-23
Immunoglobulin A Nephropathy (IgAN)
2023-506769-67-00
4
2024-09-04
Moderate to Severely Active Ulcerative Colitis
2023-509190-23-00
5
2024-09-03
Atherosclerotic Cardiovascular Disease
Elevated lp(a)
2023-505608-43-00
4
2024-07-04
Moderate to Severe Hidradenitis Suppurativa
2023-506457-38-00
5
2024-06-05
Chronic kidney disease (CKD) and hypertension.
2023-505435-12-00
5
2024-06-04
Asthma
Showing 121–144 of 231 trials